Catharina Scholl

7PUBLICATIONS
11CO-AUTHORS
PharmacogenomicsGene expression (incl. microarray and other genome-wide approaches)Respiratory diseasesGene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 10, 2024
The influence of age, gender and pharmacogenetic profiles on the perspective on medicines in the German EMPAR study.

Veronica Atemnkeng Ntam, Tatjana Huebner, Michael Steffens

|Feb 07, 2024
Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease mice.

Anna Papazoglou, Christina Henseler, Sandra Weickhardt

|Oct 23, 2021
Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?

Katja S Just, Catharina Scholl, Miriam Boehme

|Jul 02, 2021
Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe.

Tatjana Huebner, Catharina Scholl, Michael Steffens

|Oct 30, 2020
Impact of Zika Virus Infection on Human Neural Stem Cell MicroRNA Signatures.

Denna Tabari, Catharina Scholl, Michael Steffens

|Jun 13, 2020
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED Study.

Katja S Just, Harald Dormann, Marlen Schurig

Pageof 2

Frequent Collaborators

3 joint publications

Michael Steffens

2 joint publications

Katja S Just

1 joint publications

Harald Dormann

1 joint publications

Ingo Gräff